Samsung unveiled “LivingColour,” its first paint collection in six colors including “Frame Beige” and “Sero Navy Blue” to complement the Serif, Sero and Frame TVs
(Bloomberg) -- Thai Prime Minister Prayuth Chan-Ocha said his government is prepared to withdraw emergency rules banning large gatherings in the capital if the mounting protests demanding his ouster and monarchy reforms remain peaceful.Prayuth’s pledge to review the state of emergency issued last week and open the doors for talks came as thousands of protesters marched to the prime minister’s office known as the Government House in Bangkok on Wednesday. Simultaneous rallies by pro-royalist groups in support of King Maha Vajiralongkorn also raised fears of clashes between the rival groups.“I will make the first move to de-escalate this situation,” Prayuth said in a prepared speech. “I am currently preparing to lift the state of severe emergency in Bangkok and will do so promptly if there are no violent incidents.”Prayuth urged the protesters to use a special session of the parliament next week to air their grievances through lawmakers and said the government and the activists should “each take a step back” and “find solutions to the problems.”“The only way to a lasting solution for all sides that is fair for those on the streets as well as for the many millions who choose not to go on the streets, is to discuss and resolve these differences through the parliamentary process,” the prime minister said.Breaking TaboosProtests have swept Bangkok in the past week in defiance of the ban on gatherings and the threat of crackdowns by the police. Similar gatherings were also held in several cities across Thailand. They have broken long-held taboos about publicly criticizing the royal family and questioned laws that stifle discussion of the monarchy.The youth-led protesters are calling for the resignation of Prayuth’s government and a rewriting of the constitution, which was drafted by a military-appointed panel after the premier, a former army chief, took power in a 2014 coup. The activists say the charter was instrumental in helping Prayuth retain power after the 2019 elections.“The only sure way to achieve a sustainable, enduring resolution to the problems is to speak to each other, respect the due process of law, and then let the will of the people be resolved in parliament,” Prayuth said. “That is the only way.”The prime minister said it was time to break the cycle of government leaders having to face mobs of opposing groups to prevent the country from becoming ungovernable and descending into chaos.The protests are underpinned by years of sluggish growth now exacerbated by the coronavirus pandemic, which has put the Thai economy on course for its worst performance ever by derailing the two main drivers: tourism and trade. The benchmark SET Index of stocks has lost 23% this year.(Updates with comment from Prayuth in third paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The global bulk molding compounds (BMC) market was valued at US$ 1,167. 64millionin 2019 and is projected to reach US$ 1,650. 58million by 2027; it is expected to grow at a CAGR of 4. 6% during 2020–2027.New York, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bulk Molding Compound Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Resin Type, Fiber Type, and Application, and Geography" - https://www.reportlinker.com/p05978055/?utm_source=GNW Bulk Molding Compound (BMC) is manufactured by mixing unsaturated thermoset resin-like polyester resin, vinyl ester resin, or epoxy resin together with strands of chopped glass fibers, styrene, an initiator, and a filler in a mixer.The mixing for the preparation of BMC is done at room temperatures and stored at low temperatures toslowdown curing before molding. Sustainability has become an important factor in the advanced manufacturing set-up industry. The increased focus toward environment along with introduction of improved and sustainable form of materials is further expected to boost the demand for sustainable materials.BMC based products are known to have a comparatively lower environmental impact than the conventional materials, such as metals, thermoplastic polymers and concrete. Theyofferminimal impact in the manufacturing of the base material, less weight in service, better lifetime, and the ability to recycle BMC parts. Therefore, the total life cycle impact of BMC is quite lower than the other materials. Further, the presence of styrene which make BMC brittle, is a significant component BMC, is also considered safe for the environment, andit has no effect on the human body. Also, BMC has comparatively low rate of emissions; it does not generate hazardous byproducts from the production processes. Further, the BMC industry complies with the legislation stated under the REACH agreement. Due to such properties, they are increasingly being deployed in greener applications, such as production of green energy, manufacturing of small and light E-car and many other applications. Rising adoption of sustainable materials across several applications due to inclination toward green future is anticipated to drive the demand of BMC in various industries. Based on resin type, the bulk molding compounds (BMC) market is further segmented intopolyester, vinyl resin, and others.The others segment is subsegmented into vinyl ester and epoxy resin. Epoxy or glycidyl compounds include glycidyl esters, diglycidyl esters, and glycidyl amines as other types of epoxy compounds which are considered as reactive diluents and are added to basic resins so as to adjust performance features. In 2019, the polyester segment dominated the market.Polyester resins are formed by the reaction between polyols, such as glycol or ethylene glycol, and dibasic acids, such as phthalic acid or maleic acid. These unsaturated resins are combined with other chemicals called hardeners or catalysts, which changes the molecular structure of the resulting compound along with generation of heat. Methyl ethyl ketone peroxide (’MEKP’) is an example of such ’hardening’ agent. Vinyl ester resins are manufactured by reacting products of epoxy resins with ethylenically unsaturated carboxylic acids. Such thermoset resins are based upon epoxy and their properties are similar to those of the unsaturated polyester resins. Vinyl ester (VE) resins are considered as an attractive alternative used in composite materials,such as BMC. In terms of geography, the bulk molding compounds (BMC) market is further segmented into North America, Europe, AsiaPacific (APAC), South America (SAM), andthe Middle East and Africa (MEA).In 2019, Asia Pacific held the largest share of the global bulk molding compounds (BMC) market, followed by North America and Europe. The companies are continuously enhancing the overall business processes to meet the customers demand in the best possible way.BMC is extensively used in various industries such as the automotive and transportation industry, aerospace, home appliances, and electrical and electronic. The growth in these industries is projected to propel the usage and demand for BMC in the US.The demand for BMC in Canada is rising with increasing purchasing power along with rising disposable income which have,indirectly, propelled the growthof theautomotive and building and construction industries. Economy of Mexico has performed relatively well in recent years, mainly due to its thriving manufacturing sector. Mexico’s propensity for free trade enabled a rise in industrial manufacturing, production, and assembly in the country. COVID-19 outbreak started in Wuhan (China) in December 2019 and has rapidly spread around the globe. The US, India, Brazil, Russia, Spain, Mexico, and Argentinaare among the most-affected nations in terms of COVID-19 confirmed cases and pronounced deaths, as of September 2020.COVID-19 pandemic has affected economies and undertakings due to lockdowns, travel bans, and business shutdowns. The global chemicals and materials is one of the major businesses witnessing the negative impact. These factors have affected the growth of the global bulk molding compounds (BMC) market. Astar S.A., Core Molding Technologies, IDI Composites International., Toray TCAC Holding B.V., MENZOLIT, PolyntSpA, SHOWA DENKO K.K, Dasyc S.A, Lorenz Kunststofftechnik GMBH, and HGGC, LLC.are among the major players operating in the global bulk molding compounds (BMC) market. Overall size of the global bulk molding compounds (BMC) market size has been derived in accordance with both primary and secondary sources.To begin the research process begins exhaustivesecondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data as well as to gain more analytical insights into the topic. The participants typically involved in the process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specialized in the bulk molding compounds (BMC). Read the full report: https://www.reportlinker.com/p05978055/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The move comes at a time when the casino magnate's actions are being scrutinised amid an inquiry into whether Crown should be allowed to operate its A$2.2 billion ($1.56 billion) casino tower in Sydney just months before its scheduled opening. Packer had earlier this month acknowledged that Crown, in which he holds a 35% stake through his private firm Consolidated Press Holdings (CPH), published false statements by distancing itself from "junket" tour operators which brought in gamblers, largely from China. Media reports had earlier alleged that gamblers serviced by Crown had ties to organised crime.
When we think about the things we'll spend money on during retirement, a few common items may come to mind: housing, transportation, food, entertainment, and Medicare premiums. An older American turning 65 today has an almost 70% chance of needing long-term care in the future, the U.S. Department of Health and Human Services says. First, you can always pad your retirement savings in the hopes that they will suffice.
Dublin, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The "Global Rolling Stock Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering. The report provides an in-depth analysis of the global rolling stock market with description of market sizing and growth. The analysis includes market by value, by application, by type and by region. Furthermore, the report also provides detailed application, type and regional analysis.Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global rolling stock market has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.Some of the major players operating in the global rolling stock market are Siemens AG, Hitachi Ltd., CRRC Corporation Limited and Alstom SA, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are also provided.Region Coverage * North America * Asia Pacific * Europe * CIS * ROWRolling stock consists of two types of vehicles powered and non-powered vehicles. Powered vehicles include electric locomotives that run on electric power from a fuel cell or battery or overhead lines and diesel locomotives that are run by a diesel engine. Whereas, non-powered vehicles include freight wagons, passenger coaches and many more. The services provided with the help of rolling stock is further classified into two categories: passenger service and freight service. These categories are further divided on the basis of the operational characteristics. The global rolling stock market has augmented at a steady pace over the years and the market is further expected to increase progressively during the forecasted years 2020 to 2024. The market would propel with support of different growth drivers such as escalating rail infrastructure, rapid industrialization, augmenting urban population, flourishing travel and tourist industry and surging government initiative.Moreover, the market faces some challenges which are hindering the growth of the market. Some of the major challenges faced by the industry are high maintenance cost and cyber threats. Whereas, the market growth would be further supported by various market trends like the adoption of artificial intelligence, hydrogen-powered trains, digitalization, etc.Key Topics Covered: 1\. Executive Summary2\. Introduction 2.1 Rolling Stock: An Overview 2.2 Manufacturing Process of Rolling Stock 2.3 Supply Chain Management for Maintenance of Rolling Stock 2.4 Rolling Stock Segmentation: An Overview3\. Global Market Analysis 3.1 Global Rolling Stock Market: An Analysis 3.1.1 Global Rolling Stock Market by Value 3.1.2 Global Rolling Stock Market Value by Application (Freight and Passenger) 3.1.3 Global Rolling Stock Market Value by Region (North America, Europe, Asia Pacific, CIS and ROW) 3.2 Global Rolling Stock Market: Application Analysis 3.2.1 Global Freight Rolling Stock Market by Value 3.2.2 Global Passenger Rolling Stock Market by Value4\. Regional Market Analysis 4.1 Asia Pacific Rolling Stock Market: An Analysis 4.2 Europe Rolling Stock Market: An Analysis 4.3 North America Rolling Stock Market: An Analysis 4.4 CIS Rolling Stock Market: An Analysis 4.5 ROW Rolling Stock Market: An Analysis 5\. COVID-19 5.1 Impact of COVID-19 5.2 Impact of COVID-19 on Rail Transportation 5.3 Regional Impact of COVID-19 5.4 Variation in Organic Traffic6\. Market Dynamics 6.1 Growth Drivers 6.1.1 Escalating Rail Infrastructure 6.1.2 Rapid Industrialization 6.1.3 Augmenting Urban Population 6.1.4 Flourishing Travel & Tourism Industry 6.1.5 Surging Government Initiative 6.2 Challenges 6.2.1 High Maintenance Cost 6.2.2 Cyber Threat 6.3 Market Trends 6.3.1 Adoption of Artificial Intelligence 6.3.2 Hydrogen Powered Train 6.3.3 Digitalization7\. Competitive Landscape 7.1 Global Rolling Stock Market Players: A Financial Comparison 7.2 Global Rolling Stock Market Players Share 7.3 Global Rolling Stock Sales by Major Market Players8\. Company Profiles 8.1 Siemens AG 8.1.1 Business Overview 8.1.2 Financial Overview 8.1.3 Business Strategy 8.2 Alstom SA 8.2.1 Business Overview 8.2.2 Financial Overview 8.2.3 Business Strategy 8.3 CRRC Corporation Limited 8.3.1 Business Overview 8.3.2 Financial Overview 8.3.3 Business Strategy 8.4 Hitachi Ltd. 8.4.1 Business Overview 8.4.2 Financial Overview 8.4.3 Business StrategyFor more information about this report visit https://www.researchandmarkets.com/r/8xyoo6Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), a leading new energy service provider in the People’s Republic of China (the ”PRC” or “China”), announces its intention to apply for the approval of the TSX Venture Exchange (the “Exchange”) to commence a Normal Course Issuer Bid (the “NCIB”). Pursuant to the NCIB, and subject to the approval of the Exchange, the Company proposes to purchase through the facilities of the Exchange, from time to time over the next 12 months, if considered advisable, up to an aggregate of 3,270,000 common shares, being approximately 5.0% of its issued and outstanding common shares of 65,463,155 as of the date hereof. Purchases, if any, would commence through the Exchange following the release of the interim results of the Company for the nine months ended September 30, 2020. All common shares purchased by the Company will be cancelled. The Board of Directors of the Company believes that the NCIB is in the best interests of the Company.About CF Energy Corp. (Previously known as: Changfeng Energy Inc.) CF Energy Corp. is a Canadian public company currently traded on the Toronto Venture Exchange (“TSX-V”) under the stock symbol “CFY”. It is an integrated energy provider and natural gas distribution company (or natural gas utility) in the PRC. CF Energy strives to combine leading clean energy technology with natural gas usage to provide sustainable energy to its customer base in the PRC.CONTACT INFORMATIONCorporate Investment Relations Investor.email@example.comCharles Wang Executive Assistant to CEO & Chair of the Board Zhaoyu.firstname.lastname@example.orgFrederick Wong Director of the Board email@example.comForward-Looking Statements Certain statements contained in this news release, including statements regarding the Company’s intention to apply for the approval of the Exchange to commence a NCIB, the timing of any such NCIB and the potential purchase of common shares of the Company pursuant to the NCIB,constitute forward-looking statements and forward-looking information (collectively, “Forward-Looking Statements”). All statements, other than statements of historical fact, included or incorporated by reference in this document are Forward-Looking Statements, including statements regarding activities, events or developments that the Company expects or anticipates may occur in the future. These Forward-Looking Statements can be identified by the use of forward-looking words such as “will”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe” or “continue” or similar words or the negative thereof. No assurance can be given that the plans, intentions or expectations or assumptions upon which these Forward-Looking Statements are based will prove to be correct and such Forward-Looking Statements included in this news release should not be unduly relied upon.Although management believes that the expectations represented in such Forward-Looking Statements are reasonable, there can be no assurance that such expectations will prove to be correct. Such Forward-Looking Statements are not a guarantee of performance and involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such Forward-Looking Statements. These factors include, without limitation, no significant and continuing adverse changes in general economic conditions or conditions in the financial markets. Readers are cautioned that all Forward-Looking Statements involve risks and uncertainties, including those risks and uncertainties detailed in the Compnay’s filings with applicable Canadian securities regulatory authorities, copies of which are available at www.sedar.com. The Company urges readers to carefully consider those factors.The Forward-Looking Statements included in this news release are made as of the date of this document and the Company disclaims any intention or obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
(Bloomberg) -- The high-profile kidnapping of a police chief in Pakistan by official paramilitary troops signals further turmoil in a country already bracing for more protests against Prime Minister Imran Khan.Troops known as rangers raided the house of Mushtaq Ahmed Mahar, the inspector general of police in southern Sindh province. Mustafa Nawaz Khokhar, a spokesman for opposition politician Bilawal Bhutto Zardari -- whose party rules the state -- told Dunya TV the rangers forced the police chief to sign an order to arrest another opposition leader, Safdar Awan.While Khan’s pro-military government has not yet addressed the issue, army chief Qamar Javed Bajwa ordered an inquiry. A spokesman for the prime minister was not immediately available to comment, and the office of the rangers in Karachi declined to do so.Since the incident, Mahar told his officers to delay leave until the completion of the probes by the army and state government, the Sindh police said on Twitter late Tuesday. Top ranking police officers in the province have sought leave for being “ridiculed,” Khokhar said.The incident comes amid the worst turmoil in Pakistan since Khan’s rise to power about two years ago. An alliance of 11 opposition parties is holding nationwide rallies seeking his removal over food shortages and inflation, and demanding the military stop meddling in politics.The army, which has directly ruled Pakistan for about half of its existence since 1947, has historically played a key part in shaping foreign and national security policy, but has expanded its role under the current government. The army and the judiciary cannot be criticized publicly under Pakistan’s constitution.The rangers are headed by a military officer and operate under the interior ministry, according to the force’s website.The alleged kidnapping happened before the police arrested Awan -- husband of Maryam Nawaz Sharif, who is the daughter and political heir of three time premier Nawaz Sharif. Awan, who was charged with raising political slogans during a visit to the tomb of the nation’s founder Muhammad Ali Jinnah in Karachi, secured bail from the Sindh High Court.It follows the arrest of journalists and opposition leaders, some whom have been charged with treason by Khan’s government for criticizing the army.(Adds rangers detail in seventh paragraph, recasts throughout)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Exergen Corporation Launches Nurse Support Program to Ensure Every Nurse Has Access to an Accurate Thermometer at Home to Protect Themselves and Their FamiliesWATERTOWN, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) -- A series of new studies underscores the alarming toll that COVID-19 takes on frontline nurses and, ultimately, their families. The studies show that patient-facing nurses and their households have a three- and two-fold increased risk of COVID-19 hospitalization, respectively. Based on this mounting body of scientific evidence, and compounded by a severe thermometer shortage, Exergen Corporation, makers of the Exergen TemporalScanner, has announced a program to ensure that every nurse in the country has access to purchasing a TemporalScanner. The Exergen TemporalScanner is the most accurate thermometer, proven by more than 80 peer-reviewed published clinical studies, and is used in hospitals and clinics nationwide. “When it comes to fighting COVID-19, nurses and their families need and deserve the highest level of protection, beginning with taking temperature twice daily at home,” said Dr. Francesco Pompei, Ph.D. and CEO of Exergen Corporation. “As a longtime supporter of nurses, our mission is to provide them access to the most accurate thermometer available, especially given the shortages we’ve been facing since COVID-19 hit.”An important study1 in medRxiv, pending peer review, sought to determine how many patient-facing healthcare workers (e.g., nurses) in high-risk settings contracted and transmitted the novel coronavirus. Prior to this study, the risk was poorly understood. It concluded that frontline nurses had a three-fold risk of COVID-19 hospitalization, and their family members had a two-fold risk over the general population.Data2 published by the National Institutes of Health shows that among U.S. healthcare personnel with COVID-19, nurses are disproportionately affected. They account for about 30% of cases, despite contributing only about 15% of the healthcare workforce. Another study3, published in Lancet Public Health, shows that frontline healthcare nurses are at an increased risk for reporting a positive COVID-19 test, compared to the general public.In concert with its Nurse Support Program, Exergen Corporation has launched a “Twice Daily” educational campaign, showing that checking temperature only in the morning is not sufficient to detect a fever, and that it must be taken twice a day. Due to circadian effects, up to half of all fevers are missed in the morning, but none are missed in the evening, making dinnertime ideal for a second daily scan.Exergen has released an educational video to communicate why taking your temperature twice daily should be the new normal, just like wearing a mask and practicing social distancing. The company has also developed educational materials, which can be found, along with more than 80 peer-reviewed clinical studies that support Exergen’s accuracy, on Exergen’s website. For more information on the “Twice Daily” campaign, visit: https://www.exergen.com/twicedailyABOUT EXERGEN CORPORATION Exergen manufactures and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than two billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as well as in millions of homes, TemporalScanners are the 1 preference of pediatricians, 1 preference of nurses and 1 selling retail thermometer. The Exergen TemporalScanner’s accuracy is supported by more than 80 peer-reviewed published studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. For additional information, visit www.exergen.com.1 Shah et al. Risk of hospitalization with coronavirus disease 2019 in healthcare workers and their households: a nationwide linkage cohort study. medRxiv. 2020 Aug 4. doi: 10.1101/2020.08.03.20164897 2 Chou et al. Update Alert 4: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers. American College of Physicians Public Health Emergency Collection. 2020 Sep 11. doi: 10.7326/L20-1134 3 Nguyen et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 Jul 31. doi: 10.1016/ S2468-2667(20)30164-XContact: Sarah Ciuba Rosica Public Relations firstname.lastname@example.org P: 201.843.5600 F: 201.957.7163 2-14 Fair Lawn Avenue Fair Lawn, New Jersey 07410
MISSISSAUGA, Ontario, Oct. 21, 2020 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services that provides everyday Canadians a path to a better tomorrow, will hold a conference call with shareholders, analysts, and portfolio managers on Wednesday, November 4, 2020. A media release including goeasy Q3 2020 results will be issued after the market closes on Tuesday, November 3, 2020. Date: Wednesday, November 4, 2020. Time: 11:00 am ET Dial-in: US/Canada toll-free 1-866-219-5269 / International 1-703-736-7431 Passcode: 4981146 please dial in the passcode, followed by to enter the call Webcast: http://investors.goeasy.com/ Media are invited to listen to the call by telephone or through the webcast. For questions, media may contact Jason Mullins, President & CEO at 905-272-2788.After the conference call, a recording will be available until November 18, 2020 by calling 1-855-859-2056 and entering passcode number 4981146.About goeasy Ltd. goeasy Ltd., a Canadian company, headquartered in Mississauga, Ontario, provides non-prime leasing and lending services through its easyhome and easyfinancial divisions. With a wide variety of financial products and services including unsecured and secured instalment loans, goeasy aspires to help put Canadians on a path to a better financial future, as they rebuild their credit and graduate to prime lending. Customers can transact seamlessly with easyhome and easyfinancial through an omni-channel model that includes online and mobile, as well as over 400 leasing and lending locations across Canada supported by more than 2,000 employees. Throughout the company’s history, it has served over 1 million Canadians and originated over $4.2 billion in loans, with one in three customers graduating to prime credit and 60% increasing their credit score within 12 months of borrowing. goeasy is the proud recipient of several awards including Waterstone Canada’s Most Admired Corporate Cultures, Glassdoor Top CEO Award, Achievers Top 50 Most Engaged Workplaces in North America, Greater Toronto Top Employers Award, the Digital Finance Institute’s Canada’s Top 50 FinTech Companies, ranking on the TSX30 and placing on the Report on Business ranking of Canada’s Top Growing Companies. The company and its employees believe strongly in giving back to the communities in which it operates and has raised over $3 million to support its long-standing partnerships with the Boys & Girls Clubs of Canada and Habitat for Humanity.goeasy Ltd.’s. common shares are listed on the TSX under the trading symbol “GSY” and goeasy’s convertible debentures are traded on the TSX under the trading symbol “GSY-DB”. goeasy is rated BB- with a stable trend from S&P and Ba3 with a stable trend from Moody’s. Visit www.goeasy.com.Contacts: Jason Mullins President & Chief Executive Officer goeasy Ltd. (905) 272-2788 David Ingram Executive Chairman of the Board goeasy Ltd. (905) 272-2788
(Bloomberg) -- The U.S. said it found “conclusive evidence” that a Chinese company used forced labor to make extracts of the sweetener stevia, with American ports now directed to seize any shipments.Customs and Border Protection has “conclusive evidence” that Inner Mongolia Hengzheng Group Baoanzhao Agriculture, Industry and Trade Co. used convict, forced or indentured labor to make the products and that they are being or are likely to be imported to the U.S., the agency said in a statement Tuesday.Previously, in 2016, the agency temporarily detained these shipments based on “reasonable but inconclusive proof” of forced labor.The move is the latest in a string where the U.S. is raising pressure on China over some companies’ alleged ill-treatment of workers. In September, CBP said it planned a so-called withhold release order, or WRO, covering all cotton, textile and tomato products from the country’s northwestern Xinjiang region, where predominantly Muslim minority groups are allegedly being repressed. China’s Foreign Ministry has denied the allegations.In a statement to Bloomberg on Wednesday, the Foreign Ministry spokesperson’s office said it wasn’t aware of the situation and accused the U.S. of previously “cooking up so-called forced labor issues against the facts.”CBP has already issued WROs against three Xinjiang-based hair-product and garment producers in 2020 and plans six more in addition to the blanket Xinjiang order.The WROs come on top of restrictions imposed on a growing number of Chinese companies that the U.S. Commerce Department has placed on its Entity List, which curbs the firms’ access to U.S. technology and commodities.President Donald Trump, who blames China for the U.S. coronavirus outbreak, has vowed to decouple the world’s two biggest economies should he win a second term in the November election.(Adds Chinese foreign ministry comment in fifth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
USA Technologies announces date of first quarter fiscal year 2021 financial results
This industry report offers high-level financial insights to help dental practices and their CPA firms better plan for the futureCharleston, SC, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Accounting technology company Ceterus announces a comprehensive look into the financial implications of COVID-19 on dental practices with the release of their COVID-19 Dental Impact Study. The in-depth report offers a high-level view of financial performance in the dental industry and provides data-backed insights to help dental practices and their CPA firms better plan for the future.The study was conducted in partnership with dental CPA firms who leverage Ceterus’ whitelabled Dental CPA dashboard, an automated accounting and benchmarked reporting solution built specifically for CPA firms serving dentistry clients. Ceterus’ dental CPA partners provide accounting services to over 1,000 dental practices across the U.S., offering a compelling snapshot into the industry at-large. For this particular report, Ceterus analyzed anonymized accounting data from a group of these practices for the first six months of 2019 and 2020, revealing differences in key areas such as Net Operating Income, Collections, Cash Flow, Government Assistance, and Expenses. The insights uncovered will better equip dental practices and their CPA firms to close out Q4 2020 and prepare for the future.Among other key findings, the COVID-19 Dental Study shows that the majority of practices surveyed experienced a staggering 90% decrease in net operating income in April and May during the height of lockdowns. 74% of dental practices surveyed participated in a government emergency loan program of some kind. These loans caused a surge in ending cash-on-hand, with many practices nearly doubling their year-over-year cash balances in June 2020 compared to June 2019.Between unexpected losses in revenue and profitability due to shutdowns and significant cash flow adjustments provided by emergency loans, dental practices will have to navigate complex financial reporting and decision-making in the months and years to come. This unique industry study reinforces the need for accurate, automated accounting, high-quality financial data, and relationships with CPA firms who can provide trusted financial consultation. “We are proud to have incredible dental CPA partners and access to high-quality industry data that helps these firms better serve their clients,” says Ceterus CEO Levi Morehouse. “This study revealed that the dental practices who weathered COVID-19 surprisingly were those who have an industry-specific accountant who serves as their financial consultant. With data-backed advisory from their CPAs, these practices were better able to obtain relief, manage budgets, and make smart decisions based on industry benchmarks.” The newly-released COVID-19 Dental Financial Impact Study further solidifies Ceterus’ commitment to being the partner of choice for industry-focused CPA firms looking to scale their client accounting services and better serve their clients — in times of crisis and beyond. About Ceterus: Ceterus is an automated accounting and benchmarked reporting solution built to empower franchisees, small business entrepreneurs, and industry-focused CPA firms. Founded in 2008 and headquartered in Charleston, SC, Ceterus takes an innovative approach to accounting using technology backed by professionals to provide time-saving and insightful solutions. For more information, visit http://www.ceterus.com. Quick Links: * How can Ceterus help your small business or CPA firm? Find out HERE. * Interested in the latest accounting automation news from Ceterus? Check out recent insights HERE. CONTACT: William Worthy Ceterus (800) 571-6119 email@example.com
First Solar to supply 869MWDC of Series 6 modules to power six projects with lowest carbon solar Vistra Corp. Buys American, Selects First Solar PV Modules for Texas Projects Vistra Corp. has selected First Solar's high-performance photovoltaic (PV) solar modules to power its six recently announced solar energy projects across Texas. The latest additions to Vistra’s generation portfolio will be powered by solar technology that was developed and innovated in America and will include modules manufactured in Ohio.IRVING, Texas and TEMPE, Ariz., Oct. 21, 2020 (GLOBE NEWSWIRE) -- U.S.-headquartered First Solar, Inc. (Nasdaq: FSLR) today announced that Vistra Corp. (NYSE: VST) selected its high-performance photovoltaic (PV) solar modules to power its six recently announced solar energy projects across Texas. Under the agreement, First Solar will supply 869 megawatts (MW)DC of Series 6 modules to power five utility-scale solar projects, developed by Vistra, ranging from 50 to 200MWAC.“First Solar and Vistra share a culture of doing business the right way and place a strong emphasis on integrity, trust, and compliance, making this a relationship of peers. We’re proud that Vistra has chosen to trust First Solar and our technology as it continues its mission to decarbonize the electricity that is the lifeblood of the communities and businesses it serves,” said Georges Antoun, chief commercial officer, First Solar. “And as America’s solar company, we’re pleased that the latest additions to Vistra’s generation portfolio will be powered by solar technology that was developed and innovated in America, and will include modules manufactured in Ohio.”Based in Irving, Texas, Vistra is the largest competitive residential electricity provider and largest competitive power generator in the U.S. with a diverse generation portfolio of approximately 39,000 megawatts.Jim Burke, chief operating officer at Vistra, added, “We’re committed to transforming our power generation portfolio, investing in renewables, and providing our customers with the power solutions they are seeking to meet their sustainability objectives. We’re proud to take that commitment a step further by investing in powering our newest renewable energy generation assets with the leading solar technology available today. We’re confident that Series 6 is the right module and First Solar is the right partner to help us deliver our mission to net-zero.”Designed and developed at First Solar’s research and development (R&D) centers in California and Ohio, Series 6 is a uniquely American solar PV module that has set industry benchmarks for quality, durability, reliability, design, and environmental performance. The result of over $1 billion in cumulative R&D investment, each module features a layer of First Solar’s proprietary CadTel semiconductor that is one-sixth the thickness of a human hair. With a carbon footprint that is up to six times lower than crystalline silicon PV panels, Series 6 delivers a superior environmental profile and lowest carbon solar available today.First Solar is the only American company among the world’s largest solar manufacturers. It celebrated two decades since its founding in 1999 and has shipped over 25GWDC of PV modules to over 45 countries worldwide, making it the only U.S.-headquartered solar module manufacturing company to achieve this milestone. With 1.9GWDC of annualized manufacturing capacity in Ohio, First Solar is also the Western Hemisphere’s largest solar manufacturer. The Company also operates manufacturing facilities in Vietnam and Malaysia, with a global annualized Series 6 manufacturing capacity of 5.7GWDC.First Solar’s product and manufacturing processes are one of the most reliable in the PV industry. From raw materials to finished products, each module is completed within the same factory, ensuring consistent quality across global manufacturing locations. This makes First Solar stand out in an industry where most PV module manufacturers have multiple products, processes, and bill-of-materials (BoMs) across sprawling supply chains, resulting in increased variability and quality and reliability risks.About First Solar, Inc. First Solar is a leading global provider of comprehensive photovoltaic (PV) solar solutions, which use its advanced module and system technology. The company’s integrated power plant solutions deliver an economically attractive alternative to fossil-fuel electricity generation today. From raw material sourcing through end-of-life module recycling, First Solar’s renewable energy solutions protect and enhance the environment. For more information about First Solar, please visit www.firstsolar.com.For First Solar Investors This release contains forward-looking statements which are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning First Solar’s sale of 869MWDC of Series 6 modules to Vistra Energy. These forward-looking statements are often characterized by the use of words such as “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “seek,” “believe,” “forecast,” “foresee,” “likely,” “may,” “should,” “goal,” “target,” “might,” “will,” “could,” “predict,” “continue” and the negative or plural of these words and other comparable terminology. Forward-looking statements are only predictions based on our current expectations and our projections about future events and therefore speak only as of the date of this release. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these forward-looking statements for any reason, whether as a result of new information, future developments or otherwise. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the matters discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our most recent Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q, as supplemented by our other filings with the Securities and Exchange Commission. Media Reuven Proença First Solar Media firstname.lastname@example.orgInvestors Mitchell Ennis First Solar Investor Relations email@example.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/90df40fb-3c44-4f28-9dd6-bb5936807d2d
* Completed enrollment in 3 pivotal clinical trials; multiple data read outs in Q4 2021 * Released meaningful abaloparatide histomorphometry data at recent ASBMR meeting * Completed two business development transactions with existing oncology assets * Repositioned commercial effort to focus on high risk/fracture patient segment * Increased current operating leverage by re-engineering components of infrastructure WALTHAM, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) provided a general business update on progress made since May 2020. The Company will provide further updates during its third quarter earnings call and at subsequent investor conferences. The key areas of activity included as part of its update are outlined below.Clinical and Regulatory:•Patient enrollment completed for 3 Pivotal Phase III trials: ºATOM study evaluating abaloparatide injection for potential use in osteoporotic men with high risk of fracture ºwearABLe study evaluating the effects on bone mineral density of abaloparatide delivered via a novel transdermal system ºEMERALD study for use of elacestrant to treat ER+/HER2- advanced or metastatic breast cancer in men and postmenopausal women •Japan: Pivotal Phase III trial of abaloparatide injection to treat both men and postmenopausal women ºExecution success by Radius partner, Teijin Pharma ºAchieved primary endpoint: for osteoporotic patients with high risk for fractures ºNDA submitted •Europe ºSeeking guidance and clarity regarding possible regulatory re-submission •Histomorphometry Phase 2 Study data ºPresented at American Society for Bone and Mineral Research (ASBMR) in September ºStudy assessed the early effect of abaloparatide at the tissue level and demonstrated significant increases in bone formation after three months in postmenopausal women with osteoporosis Business Development•Completed transaction with Menarini Group for Elacestrant, an oral SERD ºMenarini licenses global development and commercial rights ºReceived $30 million as an upfront payment and up to $320 million in additional milestones along with tiered low to mid-teen royalties ºPhase 3 development costs to be fully reimbursed by Menarini Group •Completed transaction with Ellipses Pharma for RAD 140, an oral SARM ºEllipses responsible for all clinical development and advancement ºReceive low double-digit percentage of future economics received by Ellipses US TYMLOS Commercial Business•Re-engineering internal operations ºCombined market access with sales and marketing under one umbrella ºReduced sales territories from 159 to 109 and sales regions from 19 to 13 ºAdjusted incentive compensation plan to incentivize growth in PMO patients at high risk for fracture • Performance Measurement ºNet new patients on TYMLOS per month vs. 3 month trailing moving average ºTotal patients and duration of patients on TYMLOS vs. 3 month moving average ºNo longer focused on anabolic market share as Radius/TYMLOS business driver • Transparency of TYMLOS performance metrics for the marketplace ºCommunicate Radius net new patients each month, commencing November 2020 ºCommunicate total Radius patients quarterly, starting with Q1, 2021 results ºShare avg. Radius patient months on therapy quarterly, starting Q2, 2021 results Increasing Current Operating Leverage: * Real estate goal: reduce from ~ 60,000 to ~ 12,000 sq. ft. actioning a hybrid work model * Reduced silos at the senior level: consolidated commercial; integrated human resources, information technology, compliance, legal, QA, supply chain and real estate * Total FTE headcount reduced from ~ 400 in 2019 to 315 as of Oct. 1, 2020, an absolute reduction of more than 20 % * Capital allocation: adjusting abaloparatide planned clinical programs to focus on growth through patient segmentation and utilizing existing data with precision of message (s) * Net new patient numbers for Radius: September and October demonstrating growth from mid-year COVID-19 slow downAbout TYMLOS (abaloparatide) injectionTYMLOS® (abaloparatide) injection was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.IMPORTANT SAFETY INFORMATIONWARNING: RISK OF OSTEOSARCOMA * Abaloparatide caused a dose-dependent increase in the incidence of osteosarcoma (a malignant bone tumor) in male and female rats. The effect was observed at systemic exposures to abaloparatide ranging from 4 to 28 times the exposure in humans receiving the 80-mcg dose. It is unknown if TYMLOS will cause osteosarcoma in humans. * The use of TYMLOS is not recommended in patients at increased risk of osteosarcoma including those with Paget's disease of bone or unexplained elevations of alkaline phosphatase, open epiphyses, bone metastases or skeletal malignancies, hereditary disorders predisposing to osteosarcoma, or prior external beam or implant radiation therapy involving the skeleton. * Cumulative use of TYMLOS and parathyroid hormone analogs (e.g., teriparatide) for more than 2 years during a patient's lifetime is not recommended. Orthostatic Hypotension: Orthostatic hypotension may occur with TYMLOS, typically within 4 hours of injection. Associated symptoms may include dizziness, palpitations, tachycardia or nausea, and may resolve by having the patient lie down. For the first several doses, TYMLOS should be administered where the patient can sit or lie down if necessary.Hypercalcemia: TYMLOS may cause hypercalcemia. TYMLOS is not recommended in patients with pre-existing hypercalcemia or in patients who have an underlying hypercalcemic disorder, such as primary hyperparathyroidism, because of the possibility of exacerbating hypercalcemia.Hypercalciuria and Urolithiasis: TYMLOS may cause hypercalciuria. It is unknown whether TYMLOS may exacerbate urolithiasis in patients with active or a history of urolithiasis. If active urolithiasis or pre-existing hypercalciuria is suspected, measurement of urinary calcium excretion should be considered.Adverse Reactions: The most common adverse reactions (incidence ≥2%) are hypercalciuria, dizziness, nausea, headache, palpitations, fatigue, upper abdominal pain and vertigo.INDICATIONS AND USAGETYMLOS is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, TYMLOS reduces the risk of vertebral fractures and nonvertebral fractures.Limitations of UseBecause of the unknown relevance of the rodent osteosarcoma findings to humans, cumulative use of TYMLOS and parathyroid hormone analogs (e.g., teriparatide) for more than 2 years during a patient's lifetime is not recommended.For the TYMLOS prescribing information, including Boxed Warning, please visit www.tymlospi.comForward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. These forward-looking statements are based on management's current expectations. These statements involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any expressed or implied by the forward-looking statements. These risks include, but are not limited to, the following: uncertainty regarding the results of regulatory submissions and oversight; success of our commercial operations; success of our clinical trials and preclinical studies; risks related to manufacturing, supply and distribution; success of any collaboration, partnership, license or similar agreements; achievement of milestones; receipt of royalties or other future contingent payments; ability to implement pricing increases. These and other important risks and uncertainties discussed in our filings with the Securities and Exchange Commission, or SEC, including under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ending December 31, 2019 and subsequent filings with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.Investor Relations Contact: Elhan Webb, CFA Email: firstname.lastname@example.org Phone: 617-551-4011
Work toward passing the CFA Level 1 Certification Exam.
Community Trust Bancorp, Inc. (NASDAQ: CTBI)
Innovative Chemical Products (the ICP Group) today announces the acquisition of Leeson Polyurethanes, a leading U.K.-based manufacturer of polyurethane adhesives and coatings used in a variety of sectors and markets.
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Medley Capital Corporation (NYSE: MCC) (the “Company” or “MCC”) announced today that, it has caused notices to be issued to the holders of its 6.500% Notes due 2021 (NYSE: MCX) (the “Notes”) regarding the Company’s exercise of its option to redeem, in whole, the issued and outstanding Notes, pursuant to Section 1104 of the Indenture date as of February 7, 2012, between the Company and U.S. Bank National Association, as trustee, and Section 101(h) of the Third Supplemental Indenture dated as of December 17, 2015. The Company will redeem $74,012,825 in aggregate principal amount of the issued and outstanding Notes on November 20, 2020 (the “Redemption Date”). The Notes will be redeemed at 100% of their principal amount ($25 per Note), plus accrued and unpaid interest thereon from October 31, 2020, through, but excluding, the Redemption Date. The interest payment on the Notes to holders of record on October 15, 2020 payable on October 31, 2020 will be payable in normal course. Questions relating to the notice of redemption should be directed to U.S. Bank National Association via telephone at 1-800-934-6802. ABOUT MEDLEY CAPITAL CORPORATIONMedley Capital Corporation is a closed-end, externally managed business development company ("BDC") that has common stock which trades on the New York Stock Exchange (NYSE: MCC) and has outstanding bonds which trade on the New York Stock Exchange under the symbols (NYSE: MCV) and (NYSE: MCX). Medley Capital Corporation's investment objective is to generate current income and capital appreciation by lending to privately-held middle market companies, primarily through directly originated transactions, to help these companies expand their businesses, refinance and make acquisitions. Our portfolio generally consists of senior secured first lien loans and senior secured second lien loans. Medley Capital Corporation is externally managed by MCC Advisors LLC, which is an investment adviser registered under the Investment Advisers Act of 1940, as amended. For additional information, please visit Medley Capital Corporation at www.medleycapitalcorp.com.ABOUT MCC ADVISORS LLCMCC Advisors LLC is a subsidiary of Medley Management Inc. (NYSE: MDLY, “Medley”). Medley is an alternative asset management firm offering yield solutions to retail and institutional investors. Medley’s national direct origination franchise is a premier provider of capital to the middle market in the U.S. Medley has $3.6 billion of assets under management in two business development companies, Medley Capital Corporation (NYSE: MCC) and Sierra Income Corporation, and several private investment vehicles. Over the past 18 years, we have provided capital to over 400 companies across 35 industries in North America.1 For additional information, please visit Medley Management Inc. at www.mdly.com.Medley LLC, the operating company of Medley Management Inc., has outstanding bonds which trade on the New York Stock Exchange under the symbols (NYSE:MDLX) and (NYSE:MDLQ).Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, but are not limited to, statements regarding the the possibility that MCC may explore strategic alternatives and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions. Such forward-looking statements represent management's current expectations and are inherently uncertain. There are a number of important factors that could materially impact the value of the MCC’s common stock or cause actual results to differ materially from those indicated by such forward-looking statements. These important factors include, but are not limited to, the effects of changes in MCC’s credit rating; MCC’s ability to arrange and consummate financing or sale transactions or to access capital; whether MCC is able to generate sufficient cash flows and maintain adequate liquidity to meet its liquidity needs, service its indebtedness, repay existing debt obligations, and finance the ongoing obligations of its business; uncertainties associated with the impact from the COVID-19 pandemic, including its impact on the global and U.S. capital markets, the global and U.S. economy, the operational and financial performance of MCC’s portfolio companies, and liquidity; and the important factors discussed under the caption “Risk Factors” in Part 1. Item 1A of MCC’s Form 10-K for the fiscal year ended September 30, 2019, and its other reports filed with the Securities and Exchange Commission. These important factors, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Any such forward-looking statements represent management’s estimates as of the date of this press release. While MCC may elect to update such forward-looking statements at some point in the future, MCC disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing MCC’s views as of any date subsequent to the date of this press release.SOURCE: Medley Capital CorporationInvestor Relations Contact: Sam Anderson Head of Capital Markets & Risk Management Medley Management Inc. 212-759-0777Media Contact: Jonathan Gasthalter/Nathaniel Garnick Gasthalter & Co. LP 212-257-4170_______________ 1 Medley Management Inc. is the parent company of Medley LLC and several registered investment advisors (collectively, “Medley”). Assets under management refers to assets of Medley’s funds, which represents the sum of the net asset value of such funds, the drawn and undrawn debt (at the fund level, including amounts subject to restrictions) and uncalled committed capital (including commitments to funds that have yet to commence their investment periods). Assets under management are as of June 30, 2020.